New Player in Personal DNA Profiling Emphasizes Privacy
Jacob Goldstein writes in The Wall Street Journal Health Blog:
Another company is jumping into the growing world of direct-to-consumer DNA testing today. For $2,500, Navigenics will tell you your genetic risk for 18 different diseases â€” at least according to the best available genetic studies. Another $250 a year gets you an ongoing subscription to the companyâ€™s services.
Of course, Navigenicsâ€™ competitors â€” mainly the Google-funded 23andMe and deCODEme, an outgrowth of deCode Genetics â€” say they have tight data protection, too. The other companies charge roughly $1,000 for their service.
Read more on WSJÂ